Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 10, 2014, Pages 1372-1382

  Soffientini, Ugo ^a   Caridis, Anna Maria ^a   Dolan, Sharron ^a   Graham, Annette ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Cholesterol trafficking proteins; Dyslipidaemia; High density lipoprotein; Insulin resistance; Lipid metabolism; Steatosis

Indexed keywords

APOLIPOPROTEIN A1; CASPASE 3; CHOLESTEROL; CYTOCHROME P450 2E1; FARNESOID X RECEPTOR; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN BINDING PROTEIN 1; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN 1; STEROIDOGENIC ACUTE REGULATORY PROTEIN 3; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CARRIER PROTEINS AND BINDING PROTEINS; PROTEIN STARD1; PROTEIN STARD3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL FUNCTION; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GENE; GENE OVEREXPRESSION; GENE SILENCING; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 5; HEPATOMA CELL; HYPERLIPIDEMIA; IMMUNOBLOTTING; INSULIN RESISTANCE; LIPID ANALYSIS; LIPID HOMEOSTASIS; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIPOTOXICITY; LIVER; MALE; NONHUMAN; NR1H4 GENE; POLYMERASE CHAIN REACTION SYSTEM; PPARGCLA GENE; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RAT; REVIEW; SCL2A1 GENE; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL MODEL; ARTICLE; CASP3 GENE; CYPE1 GENE; G6PC GENE; IGFBP1 GENE; IRS1 GENE; LIPID METABOLISM; LIVER CELL CARCINOMA; OBESITY; SERPINE 1 GENE; STEATOSIS;

EID: 84904878714     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.07.002     Document Type: Article

References (53)

1. M.R. Taskinen Diabetic dyslipidaemia: from basic research to clinical practice Diabetologia 46 2003 733 749
2. A. Hiukka, J. Fruchart, E. Leinonen, H. Hilden, J. Fruchart, and M. Taskinen Alterations of lipids and apolipoprotein CIII in VLDL subspecies in type 2 diabetes Diabetologia 48 2005 1207 1215 (Pubitemid 40909658)
3. M. Adiels, M.-F. Taskinen, C. Packard, M.J. Caslake, A. Soro-Paavonen, J. Westerbacka, S. Vehkavaara, A. Hakkinen, S.-O. Olofsson, H. Yki-Jarvinen, and J. Boren Overproduction of large VLDL particles is driven by increased liver fat content in man Diabetologia 49 2006 755 765 (Pubitemid 43357551)
4. M.B. Elam, H.G. Wilcox, L.M. Cagen, X. Deng, R. Raghow, P. Kumar, M. Heimberg, and J.C. Russell Increased hepatic VLDL secretion, lipogenesis and SREBP-1 expressioin in the corpulent JCR:LA-cp rat J. Lipid Res. 42 2001 2039 2048 (Pubitemid 34001053)
5. C. Buechler, and S. Bauer ATP binding cassette transporter A1 (ABCA1) associated proteins: potential drug targets in the metabolic syndrome and atherosclerotic disease? Curr. Pharm. Biotechnol. 13 2011 319
6. L.R. Brunham, J.K. Kruit, B. Vechere, and M.R. Hayden Cholesterol in islet dysfunction and type 2 diabetes J. Clin. Invest. 118 2008 403 408 (Pubitemid 351206525)
7. M.B. Ehlers, S.M. Larson, H.E. Rasmussen, Y.K. Park, and J.T. Lee High-density lipoprotein metabolism in human (B)100 transgenic/brown adipose tissue deficiency mice: a model of obesity-induced hyperinsulinaemia Appl. Physiol. Nutr. Metab. 36 2011 334 341
8. K. Nonomura, Y. Arai, H. Mitani, S. Abe-Dohmae, and S. Yokoyama Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation Atherosclerosis 216 2011 334 341
9. Y. Uehara, T. Engel, Z. Li, C. Goepfert, S. Rust, X. Zhou, C. Langer, C. Schachtrup, J. Wiekowski, S. Lorkowski, and G. Assmann Polyunsaturated fatty acids and acetoacetate downregulate the expression of ATP binding cassette transporter A1 Diabetes 51 2002 2922 2928
10. S.M. Clee, J.J. Kastelein, M. Marcil, K. Roomp, K.Y. Zwarts, J.A. Collins, R. Roelants, N. Tamasawa, T. Stulc, T. Suda, R. Ceska, B. Boucher, C. Rondeau, C. DeSouich, A. Brooks-Wilson, H.O. Molhuizen, J. Frohlich, J. Genest Jr., and M.R. Hayden Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes J. Clin. Invest. 106 2000 1263 1270
11. S. Chung, A.K. Gebre, J. Seo, G.S. Shelness, and J.S. Parks A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion J. Lipid Res. 51 2010 729 742
12. S. Chung, J.M. Timmins, M. Duong, C. Degirolamo, R.S. Sawyer, J.K. Sawyer, R.R. Singaraja, M.R. Hayden, N. Maeda, L.L. Rudel, G.S. Shelness, and J.S. Parks Targeted deletion of hepatocytes ABCA1 leads to very low density lipoprotein overproduction and low density lipoprotein hypercatabolism J. Biol. Chem. 285 2010 12197 12209
13. M. Liu, S. Chung, G.S. Shelness, and J.S. Parks Hepatic ABCA1 and VLDL triglyceride production Biochim. Biophys. Acta 1821 2012 770 777
14. K. Cusi Role of obesity and lipotoxicity in the development of non-alcoholic steatohepatitis: pathophysiology and clinical implications Gastroenterol. 142 2012 e716
15. G.C. Farrell, D. van Rooyen, L. Gan, and S. Chitturi NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications Gut Liver 6 2012 149 171
16. G. Musso, R. Gambino, and M. Cassader Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis Prog. Lipid Res. 52 2013 175 191
17. C. Savard, E.V. Tartaglione, R. Kuver, W.G. Haigh, G.C. Farrell, S. Subramanian, A. Chait, M.M. Yeh, L.S. Quinn, and G.N. Ioannou Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis Hepatology 57 2013 81 92
18. K. Tomita, T. Teratani, T. Suzuki, M. Shimizu, H. Sato, K. Narimatsu, Y. Okada, C. Kurihara, R. Irie, H. Yokoyama, K. Shimamura, S. Usui, H. Ebinuma, H. Saito, C. Watanabe, S. Komoto, A. Kawaguchi, S. Nagao, K. Sugiyama, R. Hokari, T. Kanai, S. Miura, and T. Hibi Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in non-alcoholic steatohepatitis in mice Hepatology 59 2014 154 160
19. R.E. Soccio, and J.L. Breslow StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism J. Biol. Chem. 278 2003 22183 22186 (Pubitemid 36830262)
20. F. Alpy, and C. Tomasetto Give lipids a START: the StAR-related lipid transfer (START) domain in mammals J. Cell Sci. 188 2005 2791 2801 (Pubitemid 41136357)
21. B.J. Clark The mammalian START domain protein family in health and disease J. Endocrinol. 212 2011 257 275
22. W.M. Pandak, S. Ren, D. Marques, E. Hall, K. Redford, D. Mallonee, P. Bohdan, D. Heuman, G. Gil, and P. Hylemon Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes J. Biol. Chem. 277 2002 48158 48164 (Pubitemid 35470765)
23. S. Ren, P. Hylemon, D. Marques, E. Hall, K. Redford, G. Gil, and W.M. Pandak Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis J. Lipid Res. 45 2004 2123 2131 (Pubitemid 40990908)
24. S. Ren, P.B. Hylemon, D. Marques, E. Gurley, P. Bodhan, K. Redford, G. Gil, and W.M. Pandak Overexpression of cholesterol transporter StAR increases in vivo rates of bile acid synthesis in the rat and mouse Hepatology 40 2004 910 917 (Pubitemid 39288124)
25. E.A. Hall, S. Ren, P.B. Hylemon, D. Rodriguez-Agudo, K. Redford, D. Marques, D. Kang, G. Gil, and W.M. Pandak Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells Biochim. Biophys. Acta 1733 2005 111 119 (Pubitemid 40603654)
26. F. Alpy, A. Rousseau, Y. Schwab, F. Legueux, I. Stoll, C. Wendling, C. Spiegelhalter, P. Kessler, C. Mathelin, M.C. Rio, T.P. Levine, and C. Tomasetto STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER J. Cell Sci. 126 2013 5500 5512
27. R. van der Kant, I. Zondervan, L. Jansse, and J. Neefjes Cholesterol-binding molecules MLN64 and ORP1L mark distinct late endosomes with transporters ABCA1 and NPC1 J. Lipid Res. 54 2013 2153 2165
28. A. Rigotti, D.E. Cohen, and S. Zanlungo STARTing to understand MLN64 function in cholesterol transport J. Lipid Res. 51 2010 2015 2017
29. M. Charman, B.E. Kennedy, N. Osborne, and B. Karten MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein J. Lipid Res. 51 2010 1023 1034
30. F. Borthwick, J.M. Taylor, C. Bartholomew, and A. Graham Differential regulation of the STARD1 subfamily of START lipid trafficking proteins in human macrophages FEBS Lett. 583 2009 1147 1153
31. J.M.W. Taylor, F. Borthwick, C. Bartholomew, and A. Graham Overexpression of steroidogenic acute regulatory protein (StAR) increases macrophage cholesterol efflux to apolipoprotein AI Cardiovasc. Res. 86 2010 526 534
32. F. Borthwick, A.M. Allen, J.M. Taylor, and A. Graham Overexpression of STARD3 in human monocyte-macrophages induces an anti-atherogenic lipid phenotype Clin. Sci. (Lond) 119 2010 265 272
33. T. Ianitti, A. Graham, and S. Dolan Increased central and peripheral inflammation and inflammatory hyperalgesia in Zucker rat model of leptin receptor deficiency and genetic obesity Exp. Physiol. 11 2012 1236 1245
34. E.G. Bligh, and W.J. Dyer A rapid method for total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
35. J.E. Tichauer, M.G. Morales, L. Amigo, L. Galdames, A. Klein, V. Quinones, C. Ferrada, A.R. Alvarez, M.C. Rio, J.F. Miquel, A. Rigotti, and S. Zanlungo Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse World J. Gastroenterol. 13 2007 3071 3079 (Pubitemid 47045464)
36. S.D. Ha, S. Park, C.Y. Han, M.L. Nguyen, and S.O. Kim Cellular adaptation to anthrax lethal toxin-induced mitochondrial cholesterol enrichment, hyperpolarisation, and reactive oxygen species generation through downregulating MLN64 in macrophages Mol. Cell. Biol. 32 2012 4846 4860
37. I. Tabas Consequences of cellular cholesterol accumulation: basic concepts and physiological implications J. Clin. Invest. 100 2002 905 911
38. T. Kishida, I. Kostetskii, Z. Zhang, f Martinez, P. Liu, S.U. Walkley, N.K. Dwyer, E.J. Blanchette-Mackie, G.L. Radice, and J.F. Strauss III Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism J. Biol. Chem. 279 2004 19276 19285 (Pubitemid 38623359)
39. V.A. Zammit Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia Biochem. J. 451 2013 1 12
40. P. Puigserver Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PCG1-α Int J Obesity 29 2005 55 59
41. P. Kovacs, R.L. Hanson, Y.H. Lee, S. Kobes, P.A. Permana, C. Bogardus, and L.J. Baier The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians Diabetes 52 2003 3005 3009 (Pubitemid 37466873)
42. Y. Li, L.K. Jadhav, and Y. Zhang Bile acid receptors in non-alcoholic fatty liver disease Biochem. Pharmacol. 86 2013 1517 1524
43. J.N. Clore, J. Stillman, and H. Sugerman Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes Diabetes 49 2000 969 974 (Pubitemid 30349419)
44. T.-M. Leung, and N. Nieto CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty acid liver J. Hepatol. 58 2013 395 398
45. P. Kaur, M.D. Reis, G.R. Couchman, S.N. Forjouh, J.F. Greene Jr., and A. Asea SERPINE links obesity and diabetes: a pilot study J. Proteomics Bioinf. 3 2010 191 199
46. K. Yamaguchi, L. Yang, S. McCall, J. Huang, X.X. Yu, S.K. Pandey, S. Bhanot, B.P. Monia, Y.X. Li, and A.M. Diehl Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with non-alcoholic steatohepatitis Hepatology 45 2007 1366 1374 (Pubitemid 46918320)
47. L.L. Listenberger, X. Han, S.E. Lewis, S. Cases, R.V. Farese, D.S. Ory, and J.E. Shaffer Triglyceride accumulation protects against fatty acid-induced lipotoxicity Proc. Natl. Acad. Sci. U. S. A. 100 2003 3077 3082 (Pubitemid 36356542)
48. Q. Xiao, J. Elovson, and V.N. Schumaker Rat McA-RH7777 cells efficiently assemble rat apolipoprotein B-48 or larger fragments into VLDL but not human apolipoprotein B of any size J. Lipid Res. 41 2000 16 25
49. J. Boren, S. Rustaeus, and S.O. Olofsson Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells J. Biol. Chem. 269 1994 25879 25888 (Pubitemid 24336289)
50. T. Ota, C. Gayet, and H.N. Ginsberg Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents J. Clin. Invest. 118 2008 316 332
51. J.J.P. Liang, P. Oelkers, C. Guo, P.C. Chu, J.L. Dixon, H.N. Ginsberg, and S.L. Sturley Overexpression of human diacylglycerol acyltransferase 1, acyl-CoA:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells J. Biol. Chem. 279 2004 44938 44944 (Pubitemid 39430907)
52. P.K. Hansson, A.-K. Asztely, J.C. Clapham, and S.A. Schreyer Glucose and fatty acid metabolism in McA-RH7777 hepatoma cells vs. rat primary hepatocytes: responsiveness to nutrient availability Biochim. Biophys. Acta 1684 2004 54 62 (Pubitemid 39140868)
53. K. Tran, F. Sun, Z. Cui, G. Thorne-Tjomsland, C. St Germain, L.R. Lapierre, R.S. McLeod, J.C. Jamieson, and Z. Yao Attenuated secretion of very low density lipoproteins from McA-RH7777 cells treated with eicosapentaenoic acid is associated with impaired utilization of triacylglycerol synthesized via phospholipid remodeling Biochim. Biophys. Acta 1761 2006 463 473 (Pubitemid 43776457)